news

New target identified for vestibular diseases

22
SHARES

Researchers have discovered a potential treatment for vestibular conditions such as dizziness in animal models.

A new study has discovered a potential pathway to treat vestibular diseases. Researchers were able to regenerate hair in the inner ears of mice allowing the animals to recover vestibular function, indicating a form of treatment for conditions such as dizziness and balance disorders in humans.

The researchers, from the Stanford University School of Medicine, impaired the inner ear hair cells of mice and then measured how well they regenerated on their own. They found that about a third of the cells regenerated spontaneously but appeared immature and vestibular function was inconsistent.

Next, they manipulated Atoh1 in the mice, a transcription factor that regulates hair cell formation. In the animals that overexpressed Atoh1, as much as 70 percent of hair cells regenerated. The regenerated cells appeared relatively mature and about 70 percent of these mice recovered vestibular function.

Drug Target Review has just announced the launch of its NEW and EXCLUSIVE report examining the evolution of AI and informatics in drug discovery and development. 

In this 63 page in-depth report, experts and researchers explore the key benefits of AI and informatics processes, reveal where the challenges lie for the implementation of AI and how they see the use of these technologies streamlining workflows in the future. 

Also featured are exclusive interviews with leading scientists from AstraZeneca, Auransa, PolarisQB and Chalmers University of Technology.

FREE DOWNLOAD HERE

“This is very exciting. It’s an important first step to find treatment for vestibular disorders,” said Alan Cheng, senior author of the study. “We couldn’t get sufficient regeneration to recover function before.”

The researchers plan to study how other methods to enhance Atoh1’s function may affect regeneration.

While the finding is a proof of concept, “it has opened the door for many more possibilities that could lead to treatment in people with vestibular disorders,” said Zahra Sayyid, the lead author.

The results were published in Cell.